Advancing the applications of liquid biopsies in oncology.
Multi-omic approaches and miniaturization are transforming liquid biopsies, enhancing sensitivity and enabling real-time, minimally invasive cancer monitoring.
- Why it matters: Current limitations in detecting specific cancer biomarkers and validating analytical methods hinder broad clinical application, impacting early diagnosis and personalized treatment.
- What they did: The study reviews emerging techniques that utilize multi-omic data from circulating analytes and explores miniaturization strategies to improve detection, response monitoring, and treatment management.
- The result: These innovations are poised to significantly advance precision oncology by providing more accurate, rapid, and patient-friendly diagnostic tools, ultimately improving clinical outcomes.